Wealth Preservation Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2K Buy
614
+302
+97% +$8.04K 0.01% 334
2025
Q4
$7.77K Buy
312
+33
+12% +$832 ﹤0.01% 320
2025
Q3
$7.11K Sell
279
-326
-54% -$8.05K ﹤0.01% 323
2025
Q2
$14.7K Sell
605
-60
-9% -$1.4K 0.01% 273
2025
Q1
$16.9K Buy
+665
New +$17.4K 0.01% 277

Other funds holding PFE

Wealth Preservation Advisors's PFE Position: Q1 2026 in Review

Wealth Preservation Advisors increased its Pfizer (PFE) stake by 97% in Q1 2026, buying an estimated $8.04K and bringing the position to 614 shares worth $17.2K. The position accounts for 0.01% of the portfolio, ranked #334.

Wealth Preservation Advisors first reported a position in PFE in Q1 2025 and has held it in 5 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wealth Preservation Advisors held 614 shares of Pfizer worth $17.2K as of Q1 2026.
  • Wealth Preservation Advisors bought 302 Pfizer shares in Q1 2026, an estimated $8.04K.
  • Pfizer made up 0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #334 holding.
  • Wealth Preservation Advisors first reported a position in Pfizer in Q1 2025 and has held it in 5 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.